very low density lipoprotein receptor
Zuletzt aktualisiert 2. März 2026
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
The VLDLR gene provides instructions for making a protein called a very low-density lipoprotein (VLDL) receptor. This protein is active in many different organs and tissues, but it appears to play a particularly important role in the developing brain.
Normal function
The VLDLR gene provides instructions for making a protein called a very low-density lipoprotein (VLDL) receptor. This protein is active in many different organs and tissues, but it appears to play a particularly important role in the developing brain.
The VLDL receptor works together with a protein called reelin. Reelin fits into the VLDL receptor like a key in a lock, which triggers a series of chemical reactions within the cell. This series of reactions is known as a signaling pathway. During early brain development, the reelin signaling pathway helps guide immature nerve cells (neuroblasts) to their appropriate locations.
Conditions referring to this gene or chromosome
Other names
CARMQ1
CHRMQ1
VLDLRCH
Related patient information and medicines

Patient information leaflet
Familiäre Hypercholesterinämie
Familiäre Hypercholesterinämie is inherited high cholesterol. ...ne (apolipoprotein B): a fault with this gene means LDL cholesterol can’t bind well to LDL receptors so that blood levels of LDLDr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet and other.

Patient information leaflet
hohen Cholesterinspiegel
Cholesterol is a fat chemical (lipid) that is made in the cells in your body. Cholesterol is carried in the... When low-density lipoproteins (LDL cholesterol) carry cholesterol this is referred to as 'bad' cholesterol. Higher levels of LDL cholesterol in your blood cause an increased risk of lipoprotein disorders and cardiovascular disease (heart.

Patient information leaflet
Statine und andere lipidsenkende Medikamente
However, national guidelines recommend that people who have not been diagnosed with cardiovascular disease, but would benefit from taking a statin to... This is a 'high-intensity' statin - the aim of giving high-intensity statins is to reduce your low-density lipoprotein (LDL) cholesterol (sometimes called the 'bad cholesterol') by at least 40%..

Patient information leaflet
IgA-Nephropathie
IgA-Nephropathie is a condition in which a protein causes damage to the kidneys. The protein is called immunoglobulin A or IgA. Nephropathy means an illness that damages the kidney. The main job of the kidneys is to clear waste materials from the body and maintain a normal balance of fluids and chemicals in the body. The kidneys also have other.

Patient information leaflet
Röntgenuntersuchung
Röntgenuntersuchungen zeigen Knochen und bestimmte andere Gewebe. What are X-rays. X-rays are a type of high-energy radiation. An X-ray machine can produce short bursts of X-rays. The rays pass easily through fluids and soft tissues of the body. However, dense tissue such as bone will block some of the X-rays. (Density means how much of something there is in a.

Patient information leaflet
Kann ich Atorvastatin und Losartan zusammen einnehmen?
There is no significant interaction between atorvastatin and losartan. These two Medikamenten are very commonly prescribed together zur manage high blood pressure and high cholesterol. Du kannst nehmen atorvastatin Atorvastatin tablets and losartan Losartan - an angiotensin receptor blocker together as they do not interact with each other. Atorvastatin.
Weiterführende Lektüre und Referenzen
- very low density lipoprotein receptor; MedlinePlus, National Library of Medicine.
- Boycott KM, Bonnemann C, Herz J, Neuert S, Beaulieu C, Scott JN, Venkatasubramanian A, Parboosingh JS. Mutations in VLDLR as a cause for autosomal recessive cerebellar ataxia with mental retardation (dysequilibrium syndrome). J Child Neurol. 2009 Oct;24(10):1310-5. doi: 10.1177/0883073809332696. Epub 2009 Mar 30.
- Boycott KM, Flavelle S, Bureau A, Glass HC, Fujiwara TM, Wirrell E, Davey K, Chudley AE, Scott JN, McLeod DR, Parboosingh JS. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J Hum Genet. 2005 Sep;77(3):477-83. doi: 10.1086/444400. Epub 2005 Jul 22.
- Boycott KM, MacDonald SK, Parboosingh JS. VLDLR Cerebellar Hypoplasia. 2008 Aug 26 [updated 2020 Feb 27]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1874/
- Micalizzi A, Moroni I, Ginevrino M, Biagini T, Mazza T, Romani M, Valente EM. Very mild features of dysequilibrium syndrome associated with a novel VLDLR missense mutation. Neurogenetics. 2016 Jul;17(3):191-5. doi: 10.1007/s10048-016-0488-y. Epub 2016 Jun 2.
- Moheb LA, Tzschach A, Garshasbi M, Kahrizi K, Darvish H, Heshmati Y, Kordi A, Najmabadi H, Ropers HH, Kuss AW. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur J Hum Genet. 2008 Feb;16(2):270-3. doi: 10.1038/sj.ejhg.5201967. Epub 2007 Nov 28.
- Newman JM, Vogel H. Neuropathological findings of very low-density lipoprotein receptor-related cerebellar hypoplasia in a full-term fetus. J Neuropathol Exp Neurol. 2025 Dec 1;84(12):1135-1142. doi: 10.1093/jnen/nlaf110.
- Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT. The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor. J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
- Tissir F, Goffinet AM. Reelin and brain development. Nat Rev Neurosci. 2003 Jun;4(6):496-505. doi: 10.1038/nrn1113. No abstract available.
- Turkmen S, Hoffmann K, Demirhan O, Aruoba D, Humphrey N, Mundlos S. Cerebellar hypoplasia, with quadrupedal locomotion, caused by mutations in the very low-density lipoprotein receptor gene. Eur J Hum Genet. 2008 Sep;16(9):1070-4. doi: 10.1038/ejhg.2008.73. Epub 2008 Mar 26.
- Wali GM, Wali G. Broadening the Clinical Spectrum of Very Low Density Lipoprotein Receptor Associated Dysequilibrium Syndrome. Mov Disord Clin Pract. 2021 Apr 3;8(4):619-623. doi: 10.1002/mdc3.13184. eCollection 2021 May. No abstract available.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
2. März 2026 | Neueste Version
1 Mar 2026 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

